Investigations on anti-IGF-1R therapy response in a colorectal cancer cell line panel
<p>Therapies targeting the type 1 insulin like growth factor receptor (IGF-1R) have so far failed to show significant benefit for colorectal cancer (CRC) patients in large clinical trials, emphasising the importance of identifying biomarkers for therapy response and developing rational combina...
Main Author: | |
---|---|
Other Authors: | |
Format: | Thesis |
Language: | English |
Published: |
2016
|
Subjects: |